Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts:: Host factors, microbiological and serological characteristics

被引:20
作者
Ruotsalainen, Eeva [1 ]
Karden-Lilja, Minna [2 ]
Kuusela, Pentti [3 ]
Vuopio-Varkila, Jaana [2 ]
Virolainen-Julkunen, Anni [2 ]
Sarna, Seppo [4 ]
Valtonen, Ville [1 ]
Jaervinen, Asko [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland
[2] Natl Publ Hlth Inst, Dept Bacterial & Inflammatory Dis, Helsinki, Finland
[3] Helsinki Univ Cent Hosp Lab, Div Clin Microbiol, Helsinki, Finland
[4] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
关键词
Staphylococcus aureus; bacteraemia; endocarditis; injection drug users; pulsed-field gel electrophoresis; staphylokinase; haemolysis; protease production; Panton-Valentine leukocidin; antistaphylolysin; teichoic acid antibody;
D O I
10.1016/j.jinf.2008.01.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Endocarditis has been associated with lower mortality and fewer complications among injection drug users (IDUs) than nonaddicts in Staphylococcus aureus bacteraemia (SAB). The better prognosis of IDUs has not been clarified but it has generally been explained by younger age and other host factors. In this study, bacterial. strains, their virulence factors, and host immune responses were compared among IDUs and nonaddicts with SAB, including those with and without endocarditis. Methods: A total of 430 consecutive adult patients with methicillin-sensitive SAB were followed prospectively for 3 months. All 44 IDUs were included, and 44 nonaddicts as controls for them. According to the modified Duke criteria, 20 patients in both groups had endocarditis. For each addict without endocarditis, an age and sex matched nonaddict was selected as a control. S. aureus isolates were assigned a genotype by PFGE, Panton-Valentine leukocidin (PVL), staphylokinase (SAK), protease, and haemolysin production. Acute and convalescent sera were tested for antibodies to alpha-haemolysin (ASTA) and teichoic acid (TAA). Results: There were no differences between IDUs and nonaddicts with SAB in the proportion of patients with a deep infection (98% vs 86%, P = 0.06) or a thromboembolic complication (30% vs 14%, P = 0.12). Endocarditis among IDUs was not associated with any specific strains, and only the FIN-4 strain was observed more often in IDUs than in nonaddicts (21% vs 5%, P = 0.03). The majority of isolates (98%) were PVL negative, and there were no differences in the numbers of SAK, protease and haemolysin production among strains between IDUs and nonaddicts. However, haemolytic properties were found more frequently in strains from IDUs without endocarditis than those with endocarditis (88% vs 47%, P = 0.007). IDUs displayed more often elevated TAA titers than nonaddicts, especially in endocarditis at acute phase (33% vs 5%, P = 0.04) and at convalescent phase (50% vs 10%, P = 0.01). The ASTA titer was more frequently initially positive among IDUs without endocarditis than with endocarditis (44% vs 6%, P = 0.01). Conclusions: Characterization of the bacterial strains and their virulence factors, and host immune responses did not reveal significant differences between IDUs and nonaddicts with similar clinical picture of SAB. Serological tests were not helpful in identifying patients with endocarditis. (C) 2008 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 42 条
[1]   Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies [J].
Bassetti, S ;
Battegay, M .
INFECTION, 2004, 32 (03) :163-169
[2]   Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: A host defense role for platelet microbicidal proteins [J].
Bayer, AS ;
Ramos, MD ;
Menzies, BE ;
Yeaman, MR ;
Shen, AJ ;
Cheung, AL .
INFECTION AND IMMUNITY, 1997, 65 (11) :4652-4660
[3]   STAPHYLOCOCCUS-AUREUS BACTEREMIA - CLINICAL, SEROLOGIC, AND ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH AND WITHOUT ENDOCARDITIS [J].
BAYER, AS ;
LAM, K ;
GINZTON, L ;
NORMAN, DC ;
CHIU, CY ;
WARD, JI .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :457-462
[4]   DETECTION OF STAPHYLOCOCCUS-AUREUS BY POLYMERASE CHAIN-REACTION AMPLIFICATION OF THE NUC GENE [J].
BRAKSTAD, OG ;
AASBAKK, K ;
MAELAND, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1654-1660
[5]   STAPHYLOCOCCUS-AUREUS ENDOCARDITIS - CLINICAL MANIFESTATIONS IN ADDICTS AND NONADDICTS [J].
CHAMBERS, HF ;
KORZENIOWSKI, OM ;
SANDE, MA .
MEDICINE, 1983, 62 (03) :170-177
[6]   A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance [J].
Chang, FY ;
MacDonald, BB ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :322-332
[7]   TEICHOIC ACID ANTIBODIES IN STAPHYLOCOCCAL AND NONSTAPHYLOCOCCAL ENDOCARDITIS [J].
CROWDER, JG ;
WHITE, A .
ANNALS OF INTERNAL MEDICINE, 1972, 77 (01) :87-+
[8]   Community-acquired methicillin-resistant Staphylococcus aureus infections in France:: Emergence of a single clone that produces Panton-Valentine leukocidin [J].
Dufour, P ;
Gillet, Y ;
Bes, M ;
Lina, G ;
Vandenesch, F ;
Floret, D ;
Etienne, J ;
Richet, H .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) :819-824
[9]   Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland [J].
Fleisch, F ;
Zbinden, R ;
Vanoli, C ;
Ruef, C .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (04) :581-586
[10]   Staphylococcus aureus endocarditis -: A consequence of medical progress [J].
Fowler, VG ;
Miro, JM ;
Hoen, B ;
Cabell, CH ;
Abrutyn, E ;
Rubinstein, E ;
Corey, GR ;
Spelman, D ;
Bradley, SF ;
Barsic, B ;
Pappas, PA ;
Anstrom, KJ ;
Wray, D ;
Fortes, CQ ;
Anguera, I ;
Athan, E ;
Jones, P ;
van der Meer, JTM ;
Elliott, TSJ ;
Levine, DP ;
Bayer, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24) :3012-3021